The SCTO actively promotes adequate research funding, irrespective of the pathology. As an umbrella organisation the SCTO itself does not carry out clinical research projects nor does it provide funds for such, but it offers the infrastructure necessary for their implementation.

Funding instruments or sources of funding for clinical research are available, on the one hand, on a project basis and, on the other hand, as individual grants.

Swiss National Science Foundation:

• Investigator Initiated Clinical Trials (IICT)
• Spark - Rapid funding of unconventional ideas
• Career Tracker Cohorts (SNSF-CTCs)
• ERA-NET E-Rare on Rare Diseases
• Careers
• Project funding

Swiss Academies of Medical Sciences:

• Funding

The SCTO participates as observer in the ECRIN consortium and is the Swiss contact point for infrastructures in Switzerland in the field of clinical research.

• Research and Innovation Framework Programme of the European Union: Horizon Europe
• European Cooperation in Science and Technology: COST
• Innovative Medicines Initiative: IMI
• Programme for coordination and cooperation of research initiatives in Europe: ERANET
• European & Developing Countries Clinical Trials Partnership: EDCTP 

Further information is available at Euresearch.

SwissFoundations: swissfoundations.ch

Science Booster channel, crowdfunding platform for research projects: wemakeit.com

Individual (pharmaceutical) companies and patient organisations may also provide research funding.